Presentations -
-
薬物濃度モニタリング(TDM)に基づく投薬個別化
TANIGAWARA YUSUKE
第55回日本癌治療学会学術集会 (横浜) ,
2017.10,Symposium, workshop panel (nominated)
-
がん治療の精密医療(Precision Medicine)：薬物濃度モニタリング(TDM)に基づく投薬個別化
谷川原祐介
第55回日本癌治療学会学術集会,
2017.10,Public lecture, seminar, tutorial, course, or other speech
-
PK/PDモデリング＆シミュレーションの活用
TANIGAWARA YUSUKE
第55回日本癌治療学会学術集会 (横浜) ,
2017.10,Symposium, workshop panel (nominated)
-
Mechanistic Pharmacodynamic analysis on safety profiles of eribulin in patients with breast cancer using data obtained by post-marketing observational study
T. Kawamura, V. Fermanelli, T. Takahashi, Y. Sakata, T. Matsuoka, M. Ishii, Y. Tanigawara
15th International Congress of Therapeutic Drug Monitoring & Clinical Toxicology (Kyoto) ,
2017.09 -
Development of an S-1 dosage formula based on renal function by a prospective pharmacokinetic study
241. E. Booka, C.K. Imamura, H. Takeuchi, Y. Hamamoto, D. Gomi, T. Mizukami, T. Ichiyama, K. Tateishi, T. Takahashi, H. Kawakubo, K. Soejima, N. Boku, Y. Tanigawara, Y. Kitagawa
15th International Congress of Therapeutic Drag Monitoring & Clinical Toxicology (Kyoto) ,
2017.09,Oral presentation (general)
-
Prohibitin1, potential predictive marker of Oxaliplatin response of colorectal cancer cells
K. Hara, N. Sasaki, Y. Tanigawara
15th International Congress of Therapeutic Drag Monitoring & Clinical Toxicology (Kyoto) ,
2017.09,Poster presentation
-
Expanding the Role of LC-MS/MS in Therapeutic Drug Monitoring (TDM)
TANIGAWARA YUSUKE
15th International Congress of Therapeutic Drug Monitoring & Clinical Toxicology (Kyoto) ,
2017.09,Oral presentation (invited, special)
-
Expansion and Evolution of TDM and CT
TANIGAWARA YUSUKE
15th International Congress of Therapeutic Drug Monitoring & Clinical Toxicology (Kyoto) ,
2017.09,Symposium, workshop panel (nominated)
-
Prospective evaluation of the relationship between erlotinib concentration and efficacy in patients with non-small cell lung cancer harboring EGFR-activating mutations
239. H. Kenmotsu, C. K. Imamura, T. Kawamura, T. Oyakawa, S. Omori, K. Nakashima, K. Wakuda, A. Ono, T. Taira, T. Naito, H. Murakami, N. Yamamoto, T. Takahashi, Y. Tanigawara
European Society for Medical Oncology (Madrid) ,
2017.09,Poster presentation
-
Model-based safety analysis of oncology drugs using post-marketing real world data
TANIGAWARA YUSUKE
11th Symposium New Developments in Clinical Pharmacy and Clinical Pharmacology (Dusseldorf, Gearmany) ,
2017.06,Symposium, workshop panel (nominated)
-
Research and Application of Population Pharmacokinetics
TANIGAWARA YUSUKE
广东省医院协会药事管理专业委员会学术会议 (Guangzhou, China) ,
2017.06,Oral presentation (invited, special)
-
Mechanistic Pharmacodynamic analysis on safety profiles of eribulin in patients with breast cancer using data obtained by post-marketing observational study
T. Kawamura, V. Fermanelli, T. Takahashi, Y. Sakata, T. Matsuoka, M. Ishii, Y. Tanigawara
American Association for Cancer Research (Washington, D.C) ,
2017.04 -
同種造血幹細胞移植後のフィラデルフィア染色体陽性急性リンパ性白血病に対するダサチニブを用いた維持療法の安全性の検討 KSGCT多施設共同臨床試験(DASALL-Ⅰ)
鬼塚真仁, 青墳信之, 松浦康弘, 町田真一郎, 横山洋紀, 後藤守孝, 立花崇孝, 土岐典子, 沼田歩, 森田智視, 今村知世, 大橋一輝, 中世古知昭, 藤澤信, 谷川原祐介, 岡本真一郎,
第39回日本造血細胞移植学会総会 (松江) ,
2017.03,Oral presentation (general)
-
がん治療における薬物体内動態の意義
谷川原祐介
第57回日本肺癌学会学術集会 (福岡) ,
2016.12,Oral presentation (keynote)
-
医薬品開発における曝露－反応(Exposure-Response)関係の活用：国際動向を踏まえた曝露－反応解析の現状と方向性
TANIGAWARA YUSUKE
第37回日本臨床薬理学会学術集会 (米子) ,
2016.12,Symposium, workshop panel (nominated)
-
The New Japanese Guideline on Population Pharmacokinetics and Pharmacodynamic Analysis
TANIGAWARA YUSUKE
East Asia(A3) Pharmacometrics Symposium (Daejeon、Korea) ,
2016.10,Oral presentation (invited, special)
-
Implementation of pharmacogenomics-informed personalized dosing
Tanigawara Yusuke
The 6th National Annual Conference on Therapeutic Drug Monitoring (China) ,
2016.09,Oral presentation (invited, special)
-
Individualized Pharmacotherapy based on Therapeutic Drug Monitoring
Tanigawara Yusuke
The China-Japan Friendship Hospital's First International Forum on Individualized Pharamcotherapy (China) ,
2016.09,Oral presentation (invited, special)
-
Population PK/PD and TDM for personalized cancer care
Tanigawara Yusuke
IATDMCT Asia & Pacific Regional Meeting 2016 (China) ,
2016.08,Oral presentation (invited, special)
-
Prospective evaluation of serum unbound fraction of docetaxel as a key determinant of its pharmacokinetics and neutropenia in the elderly
237. H. Kenmotsu, C. K. Imamura, A. Ono, S. Omori, K. Nakashima, K. Wakuda, T. Taira, T. Naito, H. Murakami, T. Takahashi, Y. Tanigawara
第14回日本臨床腫瘍学会学術集会 (神戸) ,
2016.07,Poster presentation